In March 2025, the company declared new plans for a immediate-to-buyer providing of its Wegovy weight loss drug. The company proven a fresh pharmacy, named NovoCare, which might cost shoppers $499 each month for entry to the drug, fewer than half the price of the drug by other pharmaceutical distribution networks.[fifty three]A weight loss plateau